Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation?
Forssberg
H
H
Department of Woman & Child Health, Karolinska Institute, Stockholm, Sweden.
Tedroff
K B
KB
D000293:Adolescent; D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D016896:Treatment Outcome
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins